BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30691086)

  • 1. Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation.
    Baird NL; Zhu S; Pearce CM; Viejo-Borbolla A
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30691086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The variegate neurological manifestations of varicella zoster virus infection.
    Gilden D; Nagel MA; Cohrs RJ; Mahalingam R
    Curr Neurol Neurosci Rep; 2013 Sep; 13(9):374. PubMed ID: 23884722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.
    Steain M; Sutherland JP; Rodriguez M; Cunningham AL; Slobedman B; Abendroth A
    J Virol; 2014 Mar; 88(5):2704-16. PubMed ID: 24352459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in Varicella Zoster Virus Vasculopathy.
    Nagel MA; Gilden D
    Curr Neurol Neurosci Rep; 2016 Feb; 16(2):12. PubMed ID: 26750127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complications of varicella zoster virus reactivation.
    Nagel MA; Gilden D
    Curr Opin Neurol; 2014 Jun; 27(3):356-60. PubMed ID: 24792344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: The neurobiology of varicella zoster virus infection.
    Gilden D; Mahalingam R; Nagel MA; Pugazhenthi S; Cohrs RJ
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):441-63. PubMed ID: 21342215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV).
    Kennedy PG
    Neurotherapeutics; 2016 Jul; 13(3):509-13. PubMed ID: 27032406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the host immune response in human Ganglia after herpes zoster.
    Gowrishankar K; Steain M; Cunningham AL; Rodriguez M; Blumbergs P; Slobedman B; Abendroth A
    J Virol; 2010 Sep; 84(17):8861-70. PubMed ID: 20573825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies.
    Hakami MA; Khan FR; Abdulaziz O; Alshaghdali K; Hazazi A; Aleissi AF; Abalkhail A; Alotaibi BS; Alhazmi AYM; Kukreti N; Binshaya AS
    Rev Med Virol; 2024 Jul; 34(4):e2554. PubMed ID: 38862398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VZV infection of keratinocytes: production of cell-free infectious virions in vivo.
    Gershon MD; Gershon AA
    Curr Top Microbiol Immunol; 2010; 342():173-88. PubMed ID: 20225011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of Varicella-Zoster Virus Infection.
    Laing KJ; Ouwendijk WJD; Koelle DM; Verjans GMGM
    J Infect Dis; 2018 Sep; 218(suppl_2):S68-S74. PubMed ID: 30247598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella-zoster virus infection of human neural cells in vivo.
    Baiker A; Fabel K; Cozzio A; Zerboni L; Fabel K; Sommer M; Uchida N; He D; Weissman I; Arvin AM
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10792-7. PubMed ID: 15247414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rodent models of varicella-zoster virus neurotropism.
    Cohen JI
    Curr Top Microbiol Immunol; 2010; 342():277-89. PubMed ID: 20225012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus VLT-ORF63 fusion transcript induces broad viral gene expression during reactivation from neuronal latency.
    Ouwendijk WJD; Depledge DP; Rajbhandari L; Lenac Rovis T; Jonjic S; Breuer J; Venkatesan A; Verjans GMGM; Sadaoka T
    Nat Commun; 2020 Dec; 11(1):6324. PubMed ID: 33303747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.
    Gershon AA; Gershon MD
    Trans Am Clin Climatol Assoc; 2016; 127():282-299. PubMed ID: 28066065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella zoster virus (VZV) infects and establishes latency in enteric neurons.
    Chen JJ; Gershon AA; Li Z; Cowles RA; Gershon MD
    J Neurovirol; 2011 Dec; 17(6):578-89. PubMed ID: 22190254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical reactivation of varicella zoster virus in all stages of HIV infection.
    Birlea M; Arendt G; Orhan E; Schmid DS; Bellini WJ; Schmidt C; Gilden D; Cohrs RJ
    J Neurol Sci; 2011 May; 304(1-2):22-4. PubMed ID: 21419427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children.
    Gershon AA; Chen J; Davis L; Krinsky C; Cowles R; Reichard R; Gershon M
    Trans Am Clin Climatol Assoc; 2012; 123():17-33; discussion 33-5. PubMed ID: 23303966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive shingles in a toddler due to reactivation of Varicella Zoster vaccine virus four days after infection with SARS-CoV-2; a case report.
    Miller C; Taylor-Salmon E; Emuren L; Landry M; Gershon A; Miller G
    BMC Infect Dis; 2023 Dec; 23(1):854. PubMed ID: 38057696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of varicella zoster virus reactivation.
    Nagel MA; Gilden D
    Curr Treat Options Neurol; 2013 Aug; 15(4):439-53. PubMed ID: 23794213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.